FDA approves Actavis, Valeant drugs for irritable bowel syndrome
May 27, 2015 at 17:02 PM EDT
WASHINGTON, May 27 (Reuters) - U.S. health regulators approved new irritable bowel syndrome drugs from Actavis Plc and Valeant Pharmaceuticals International Inc on Wednesday, validating big investments both companies made to acquire the products.